Labcorp Holdings (LH) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Labcorp Holdings Inc. (NYSE: LH - Get Free Report) EVP Brian Caveney sold 2,000 shares of the stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $372.04, for a total value of $7…

Fifth Third Bancorp lessened its position in Labcorp Holdings Inc. (NYSE: LH) by 12.4% during a recent quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4…

Eurizon Capital SGR S.p.A. lowered its position in Labcorp Holdings Inc. (NYSE: LH) by 16.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. …

Labcorp NYSE: LH Chief Financial Officer Julia Wang said strength in the company's central laboratory business and diagnostic testing helped drive third-quarter growth, while management prepares for a potential reduction…

Revenue grew 7% to $3.8 billion in the third quarter. Proposed Medicare fee schedule changes present a $125 million potential impact.…

Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript…

LH's specialty testing growth, AI-driven efficiencies and expanding margins support its outlook, though currency pressures and competition pose risks.…

Labcorp Holdings Inc. (NYSE: LH - Get Free Report)'s stock price reached a new 52-week high on Thursday after HSBC upgraded the stock from a hold rating to a buy rating. HSBC now has a $410.00 price target on the stock. …

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.…

BURLINGTON, N.C., Nov. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that Chief Financial Officer Julia Wang will speak at the UBS Global…

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.…

Labcorp (NYSE: LH) reported third-quarter 2026 revenue growth, margin expansion and double-digit adjusted earnings-per-share growth, prompting the laboratory services company to raise the midpoint of its full-year revenu…

Labcorp Holdings raised guidance, triggering a sharp stock price rally. I view LH as a compelling long-term growth story, but current valuation is stretched. The price-earnings ratio approaching 20 exceeds my preferred r…

Labcorp Holdings Inc. (LH) Q3 2026 Earnings Call Transcript…

Labcorp Holdings (NYSE:LH) stock is trading at a 52-week high after the company reported upbeat third-quarter earnings and raised its fiscal outlook.…

Labcorp shares rise as Q3 earnings and revenues beat estimates, both segments deliver growth, margins expand and the company raises its 2026 financial outlook.…

Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the …

Labcorp Holdings (LH) came out with quarterly earnings of $4.78 per share, beating the Zacks Consensus Estimate of $4.65 per share. This compares to earnings of $4.18 per share a year ago.…

Results from operations for third quarter 2026 versus third quarter 2025: Revenue: $3.81 billion vs. $3.56 billion, up 6.9% Diluted EPS: $3.22 vs.…

WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer screening.…

Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center, …

Research collaboration aims to strengthen the science used to assess whether new medicines could be abused, supporting safer drug development and more informed regulatory decisions BURLINGTON, N.C., Oct. 22, 2026 /PRNews…

Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?…

BURLINGTON, N.C., Oct. 21, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash divid…

SALT LAKE CITY and BURLINGTON, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE: LH), a global leader in inn…

Acquisition will expand access to clinical laboratory services, including a broad specialty testing menu for patients and providers nationwide BURLINGTON, N.C. and MIAMI, Fla.…

First lab test offered in collaboration with Thrive Global Combines Labcorp's scientific expertise with Thrive Global's behavior change approach to help consumers turn health insights into healthier daily habits Delivers…

BURLINGTON, N.C., Sept. 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc.…

Reaffirms full-year 2026 guidance Provides long-term outlook through 2029, with compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share (EPS) growth of 8.5% to 11.5% Outlines strategic …
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Feb 12. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

